Cocrystal Pharma Inc — Cash Flow (NASDAQ:COCP) | MetaTrader

Open full chart

Financials

Overview 明細書 Statistics Dividends

Quarterly Annual

Cash from operating activities 9.83 M-12.72 M-21.43 M-14.67 M16.5 M -3.28 M Cash from investing activities 240 K52 K74 K118 K8 000 12 K Cash from financing activities 35.66 M38.47 M27 K3.99 M0 — Free cash flow 9.59 M-12.77 M-21.51 M-14.78 M16.49 M -3.29 M

ニュース

Cocrystal Pharma advances norovirus drug candidate to Phase 1b trial

Tuesday’s Insider Activity: Major Buys at CBC, COCP; Sells at ARES, RKLB

フィリップ・フロスト、ココリスタル・ファーマ（COCP）株を18,812ドル分購入

Phillip Frost buys Cocrystal Pharma (COCP) shares worth $18,812

Cocrystal Pharma raises $1.03 million in private placement from directors

Cocrystal Pharma receives $500,000 NIH grant for influenza drug

コクリスタル・ファーマ、4.7百万ドルの登録直接募集を完了

Cocrystal Pharma closes $4.7 million registered direct offering

コクリスタル・ファーマ、ナスダック規則に基づく登録直接募集で4.7百万ドル調達

Cocrystal Pharma raises $4.7 million in registered direct offering

コクリスタルのノロウイルス薬CDI-988、第1b相試験へ進展

Cocrystal’s norovirus drug CDI-988 advances to phase 1b study